Douglas Research Insights

Douglas Research Insights

Share this post

Douglas Research Insights
Douglas Research Insights
Corporate Value Up in Korea - Focus On Reducing Outstanding Shares and Comparison to M7
Copy link
Facebook
Email
Notes
More

Corporate Value Up in Korea - Focus On Reducing Outstanding Shares and Comparison to M7

Douglas Kim's avatar
Douglas Kim
Sep 05, 2024
∙ Paid

Share this post

Douglas Research Insights
Douglas Research Insights
Corporate Value Up in Korea - Focus On Reducing Outstanding Shares and Comparison to M7
Copy link
Facebook
Email
Notes
More
1
Share
  • In this insight, we compare the outstanding shares changes in the Korean stock market (KOSPI and KOSDAQ) relative to M7 (Magnificent 7) companies.

  • In Korea, there are more companies such as Samsung C&T, KB Financial, and KT&G that are actively reducing their outstanding shares and investors are rewarding them with higher share prices.

  • Top 10 companies in KOSPI that reduced their outstanding shares (from end of 2019 to 5 Sept 24) experienced average share price increase of 116% on average in this period.

city with high-rise buildings during night time
Photo by Ethan Brooke on Unsplash

Comparison of KOSPI and KOSDAQ vs M7 Companies

One of the key reasons for the "Korea Discount" in the Korean stock market is the lack of aggressive efforts to reduce outstanding shares. When the number of shares increases, shareholder value is diluted, so even if the market capitalization increases, the index does not rise.

According to the Korea Exchange, the combined number of issued shares of companies in KOSPI and KOSDAQ increased by 107.2% from 57.1 billion in 2014 to 118.3 billion as of 3 September, 2024. KOSPI increased from 35.4 billion shares to 62.7 billion shares, and KOSDAQ increased from 21.7 billion shares to 55.6 billion shares.

During the same period, the market caps of KOSPI and KOSDAQ doubled from 1,366 trillion won to 2,570 trillion won. However, KOSPI and KOSDAQ have only risen by about 35% each from the end of 2014 to 3 September 2024.

Keep reading with a 7-day free trial

Subscribe to Douglas Research Insights to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Douglas Kim
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More